Alimta
- Product NDC
- 0002-7623
- 11-digit product format
- 000027623
- Labeler code
- 0002
- Product ID
- 0002-7623_3af0bc84-13d6-46aa-a4c0-c62410b73bc6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Pemetrexed disodium
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Eli Lilly and Company
- Application
- NDA021462
- Marketing category
- NDA
- Marketing start
- 2004-02-04
- Substance
- PEMETREXED DISODIUM HEPTAHYDRATE
- Active strength
- 500 mg/20mL
- Pharmacologic classes
- Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Alimta
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| PEMETREXED DISODIUM HEPTAHYDRATE | 500 mg/20mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 9T47E4OM16 |
| Rxcui | 1728072, 1728075, 1728077, 1728079 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0002-7623-01 | Alimta | 1 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 1 | | 59 |
| 0002-7623-01 | Alimta | 20 mL in 1 VIAL | INJECTION, POWDER, LYOPHILIZED, | 20 | | 59 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| Pemetrexed disodium heptahydrate | ACTIVE INGREDIENT | 9T47E4OM16 | ALIMTA (PEMETREXED DISODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ELI LILLY AND COMPANY] | 43 | |
| Pemetrexed | ACTIVE MOIETY | 04Q9AIZ7NO | ALIMTA (PEMETREXED DISODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ELI LILLY AND COMPANY] | 43 | |
| Hydrochloric acid | INACTIVE INGREDIENT | QTT17582CB | ALIMTA (PEMETREXED DISODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ELI LILLY AND COMPANY] | 43 | |
| Mannitol | INACTIVE INGREDIENT | 3OWL53L36A | ALIMTA (PEMETREXED DISODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ELI LILLY AND COMPANY] | 43 | |
| Sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | ALIMTA (PEMETREXED DISODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ELI LILLY AND COMPANY] | 43 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0002-7623 | ALIMTA (PEMETREXED DISODIUM) INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ELI LILLY AND COMPANY] | 59 | Current NDC, Legacy NDC, 2 package rows | 20230628_f5a860f3-37ec-429c-ae04-9c88d7c55c08.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0002-7623-01 | 00002762301 | 1 VIAL in 1 CARTON (0002-7623-01) / 20 mL in 1 VIAL | 1 vial | 2004-02-13 | 0000-00-00 | No | No | Current |